6 completed, 1 withdrawn. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Selecta Biosciences, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA SEL-302 - Methylmalonic Acidemia (MMA) | Phase 1 / Phase 2 | Withdrawn | Selecta Biosciences, Inc. | 2022-12-19 | 2024-09-24 | |
| A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy SEL-212, KRYSTEXXA® - Chronic Gout | Phase 2 | Completed | Selecta Biosciences, Inc. | 170 | 2019-05-07 | 2023-10-17 |
| Safety and Pharmacodynamcis of SELA-070 Nicotine Vaccine in Smokers SELA-070, Saline - Smoking Cessation | Phase 1 | Completed | Selecta Biosciences, Inc. | 72 | 2017-05-11 | 2018-11-16 |
| Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid SEL-212, SEL-037, SVP-rapamycin (SEL-110) - Gout Chronic, Hyperuricemia | Phase 2 | Completed | Selecta Biosciences, Inc. | 152 | 2016-10-01 | 2022-02-14 |
| Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels SEL-110, SEL-212, SEL-037 - Gout | Phase 1 | Completed | Selecta Biosciences, Inc. | 63 | 2015-12-01 | 2017-01-30 |
| Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels SEL-037 (pegsiticase) - Gout | Phase 1 | Completed | Selecta Biosciences, Inc. | 22 | 2015-05-01 | 2016-10-21 |
| Safety and Pharmacodynamics of SEL-068 Vaccine in Smokers and Non-Smokers SEL-068, Saline - Smoking Cessation | Phase 1 | Completed | Selecta Biosciences, Inc. | 82 | 2011-11-01 | 2016-01-07 |
Gout (2) · Smoking Cessation (2) · Hyperuricemia (1) · Methylmalonic acidemia (1)
Sodium Chloride (2) · Pegloticase (1)
United States (5) · Belgium (2)
Alexander Lucardie, MD (1) · Eva Vets, MD (1)
PMID 35022448, PMID 37069364, PMID 37449908
2017 (1)